AAAhmad Altayyar

Ahmad Altayyar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmad Altayyar has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bayode Oluwawibe

    Cancer Research and Molecular Biology Laboratories Department of Biochemistry Faculty of Basic Medical Sciences University of Ibadan Ibadan Oyo State Nigeria

    1 shared publication
  • Chima Amadi

    Dedra Nutraceuticals and Biotechnology Initiative, Abuja FCT Garki 900024 Nigeria

    1 shared publication
  • Chioma E. Irozuru

    Department of Chemistry and Biochemistry Montana State University Bozeman MT 59719 USA

    1 shared publication
  • Harieme Agbarogi

    Cancer Research and Molecular Biology Laboratories Department of Biochemistry Faculty of Basic Medical Sciences University of Ibadan Ibadan Oyo State Nigeria

    1 shared publication
  • Jesutosin O. Babalola

    Nutrition and Industrial Biochemistry Research Laboratories Department of Biochemistry Faculty of Basic Medical Sciences University of Ibadan Ibadan Oyo State Nigeria

    1 shared publication
  • Moses T. Otunla

    Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY 40536, USA

    1 shared publication

Latest Publications

  • Open Access

    Dietary Berberine Reduced Oxido‐Inflammatory Stress in Rats' Livers and Kidneys, Supplemented from Prepuberty to Adulthood

    by Solomon Owumi, Bayode Oluwawibe, Harieme Agbarogi, Moses T. Otunla, Uche Arunsi, Jesutosin O. Babalola, Chioma Irozuru, Chima Amadi, Ahmad Altayyar

    Berberine (BER), an alkaloid found in plants like Berberis vulgaris, has beneficial biological effects. Targeting the prepubertal‐to‐adulthood transition, a critical period of growth and metabolic programming, this study investigated whether early‐life BER supplementation confers lasting hepatorenal protection against oxido‐inflammatory stress. Rats received BER (25‐200 mg/kg) from the prepubertal stage (3 weeks old) to adulthood. The study assessed liver and kidney function, oxidative, nitrosative, inflammatory biomarkers, and tissue histopathology. Rats treated with BER (25‐100 mg/kg) showed significant ( p < 0.05 ) dose‐dependent increase in body weight gain compared to the control, suggestive of improved nutrient utilization and growth. BER decreased urea, creatinine, and hepatic transaminase levels and increased antioxidant enzymes, glutathione, and total thiols levels. Also, BER treatment reduced biomarkers of oxido‐inflammatory stress in the liver and kidney, including nitric oxide, TNF‐alpha, xanthine oxidase, myeloperoxidase, malondialdehyde (MDA), reactive oxygen species, and protein carbonyls ( p < 0.05 ). Histological examination revealed healthier liver and kidney tissues in the BER‐treated rats relative to the untreated control. It can be adduced that BER improved cellular redox balance, reduced pro‐inflammatory mediators, and likely promoted the histoarchitectural integrity of the experimental rat liver and kidney with the likely tendency to abate a permissive cellular environment that may result in an adverse pathophysiological state.